Claims for Patent: 7,183,282

Summary for Patent: 7,183,282

Title:	Substituted heterocycle fused .gamma.-carbolines
Abstract:	The present invention is directed to compounds useful for treating addictive behavior and sleep disorders represented by structural Formula (I) ##STR00001## or pharmaceutically acceptable salt forms thereof, wherein R.sup.1, R.sup.5, R.sup.6a, R.sup.6b, R.sup.7, R.sup.8, R.sup.9, X, b, k, m, and n, and the dashed lines are described herein. The compounds used in the method of treatment of this invention are serotonin agonists and antagonists and are useful in the control or prevention of central nervous system disorders including addictive behavior and sleep disorders.
Inventor(s):	Robichaud; Albert J. (Ringoes, NJ), Lee; Taekyu (Doylestown, PA), Deng; Wei (Lexington, MA), Mitchell; Ian S. (Lafayette, CO), Yang; Michael G. (Narberth, PA), Haydar; Simon (Newtown, PA), Chen; Wenting (Langhorne, PA), McClung; Christopher D. (Chicago, IL), Calvello; Emilie J. (Baltimore, MD), Zawrotny; David M. (Ann Arbor, MI)
Assignee:	Bristol-Myers Squibb Pharma Company (Princeton, NJ)
Application Number:	11/375,125
Patent Claims:	1. A compound or a pharmaceutically acceptable salt form thereof according to the following formula: ##STR00062## 2. A compound or a pharmaceutically acceptable salt form thereof according to the following formula: ##STR00063## 3. A pharmaceutical composition, comprising: the compound according to claim 1; and at least one pharmaceutically acceptable carrier or diluent. 4. A pharmaceutical composition, comprising: the compound according to claim 2; and at least one pharmaceutically acceptable carrier or diluent.